Skip to main content

Table 5 Average cost-effectiveness (CE) and incremental cost-effectiveness (ICE) ratio of assessed antipsychotics versus haloperidol (€, 2009)

From: Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses

Strategy Average CE ratio (€/QALY) ICE ratio (€/QALY gained) versus haloperidol
Amisulpride 5,792 91,584
Aripiprazole 6,386 94,558
Haloperidol 4,593 NA
Olanzapine 5,208 23,621
Paliperidone ER 4,043 Dominant
Risperidone 4,353 Dominant
  1. Dominant: strategy with higher effectiveness (QALYs) and lower cost